nafamostat has been researched along with Hypersensitivity in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Hypersensitivity: Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, M | 1 |
| Shibata, K | 1 |
| Akatsu, H | 1 |
| Shimizu, N | 1 |
| Sakata, N | 1 |
| Katsuragi, T | 1 |
| Okada, H | 1 |
1 other study available for nafamostat and Hypersensitivity
| Article | Year |
|---|---|
Contribution of anaphylatoxin C5a to late airway responses after repeated exposure of antigen to allergic rats.
Topics: Airway Resistance; Animals; Antigens; Antigens, CD; Asthma; Benzamidines; Bronchi; Bronchoalveolar L | 2001 |